Chronic immune-related adverse events arising from immune checkpoint inhibitors: an update

被引:14
作者
Fletcher, Kylie [1 ]
Johnson, Douglas B. [2 ]
机构
[1] Vanderbilt Univ, Sch Med, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Dept Hematol Oncol, Nashville, TN 37232 USA
关键词
Immune related adverse event - irAE; Neurotoxicity; Thyroid toxicity; Immune Checkpoint Inhibitor; PHASE-I; IPILIMUMAB; NIVOLUMAB; MELANOMA; PD-1; TOXICITIES; DISORDERS; SURVIVORS; ANTIBODY; RECEPTOR;
D O I
10.1136/jitc-2023-008591
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Immune checkpoint inhibitors (ICIs) have transformed cancer treatment, improving outcomes for many patients. However, toxicities termed immune-related adverse events (irAEs) are limitations of these revolutionary treatments. These irAEs may resolve with treatment or ICI cessation (acute) or persist many months beyond therapy cessation (chronic). Acute irAEs were the first to be recognized and are thus more well studied. However, chronic irAEs have been highlighted in recent years and are becoming a topic of more intensive investigation. These chronic irAEs have been noted to affect many different organ systems, including endocrine, rheumatologic, gastrointestinal, dermatologic, neurologic, and cardiovascular systems. In this review, we discuss current knowledge surrounding the frequency, time course, and risk factors associated with chronic irAEs affecting various organ systems, treatment approaches, and future directions.
引用
收藏
页数:10
相关论文
共 103 条
[1]   Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation [J].
Anderson, Ana C. ;
Joller, Nicole ;
Kuchroo, Vijay K. .
IMMUNITY, 2016, 44 (05) :989-1004
[2]   Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade [J].
Andrews, Miles C. ;
Duong, Connie P. M. ;
Gopalakrishnan, Vancheswaran ;
Iebba, Valerio ;
Chen, Wei-Shen ;
Derosa, Lisa ;
Khan, Md Abdul Wadud ;
Cogdill, Alexandria P. ;
White, Michael G. ;
Wong, Matthew C. ;
Ferrere, Gladys ;
Fluckiger, Aurelie ;
Roberti, Maria P. ;
Opolon, Paule ;
Alou, Maryam Tidjani ;
Yonekura, Satoru ;
Roh, Whijae ;
Spencer, Christine N. ;
Curbelo, Irina Fernandez ;
Vence, Luis ;
Reuben, Alexandre ;
Johnson, Sarah ;
Arora, Reetakshi ;
Morad, Golnaz ;
Lastrapes, Matthew ;
Baruch, Erez N. ;
Little, Latasha ;
Gumbs, Curtis ;
Cooper, Zachary A. ;
Prieto, Peter A. ;
Wani, Khalida ;
Lazar, Alexander J. ;
Tetzlaff, Michael T. ;
Hudgens, Courtney W. ;
Callahan, Margaret K. ;
Adamow, Matthew ;
Postow, Michael A. ;
Ariyan, Charlotte E. ;
Gaudreau, Pierre-Olivier ;
Nezi, Luigi ;
Raoult, Didier ;
Mihalcioiu, Catalin ;
Elkrief, Arielle ;
Pezo, Rossanna C. ;
Haydu, Lauren E. ;
Simon, Julie M. ;
Tawbi, Hussein A. ;
McQuade, Jennifer ;
Hwu, Patrick ;
Hwu, Wen-Jen .
NATURE MEDICINE, 2021, 27 (08) :1432-+
[3]  
[Anonymous], 2023, Programmed death-1 (PD-1)deficient mice are extraordinarily sensitive to tuberculosis-PMC
[4]  
[Anonymous], 2022, Opdualag Approved to Treat Advanced Melanoma-NCI
[5]   Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case report [J].
Appelbaum, Jacob ;
Wells, David ;
Hiatt, Joseph B. ;
Steinbach, Gideon ;
Stewart, F. Marc ;
Thomas, Hannah ;
Nghiem, Paul ;
Kapur, Raj P. ;
Thompson, John A. ;
Bhatia, Shailender .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
[6]   Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis [J].
Badran, Yousef R. ;
Zou, Fangwen ;
Durbin, Sienna M. ;
Dutra, Barbara E. ;
Abu-Sbeih, Hamzah ;
Thomas, Anusha S. ;
Altan, Mehmet ;
Thompson, John A. ;
Qiao, Wei ;
Leet, Donna E. ;
Lai, Po-Ying ;
Horick, Nora K. ;
Postow, Michael A. ;
Faleck, David M. ;
Wang, Yinghong ;
Dougan, Michael .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (06)
[7]   Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti-PD-1 Monotherapy [J].
Bai, Xue ;
Hu, Jiani ;
Warner, Allison Betof ;
Quach, Henry T. ;
Cann, Christopher G. ;
Zhang, Michael Z. ;
Si, Lu ;
Tang, Bixia ;
Cui, Chuanliang ;
Yang, Xiaoling ;
Wei, Xiaoting ;
Pallan, Lalit ;
Harvey, Catriona ;
Manos, Michael P. ;
Ouyang, Olivia ;
Kim, Michelle S. ;
Kasumova, Gyulnara ;
Cohen, Justine V. ;
Lawrence, Donald P. ;
Freedman, Christine ;
Fadden, Riley M. ;
Rubin, Krista M. ;
Sharova, Tatyana ;
Frederick, Dennie T. ;
Flaherty, Keith T. ;
Rahma, Osama E. ;
Long, Georgina V. ;
Menzies, Alexander M. ;
Guo, Jun ;
Shoushtari, Alexander N. ;
Johnson, Douglas B. ;
Sullivan, Ryan J. ;
Boland, Genevieve M. .
CLINICAL CANCER RESEARCH, 2021, 27 (21) :5993-6000
[8]   Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes [J].
Balaji, Aanika ;
Hsu, Melinda ;
Lin, Cheng Ting ;
Feliciano, Josephine ;
Marrone, Kristen ;
Brahmer, Julie R. ;
Forde, Patrick M. ;
Hann, Christine ;
Zheng, Lei ;
Lee, Valerie ;
Illei, Peter B. ;
Danoff, Sonye K. ;
Suresh, Karthik ;
Naidoo, Jarushka .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (01)
[9]   Chronic immune-related adverse events in patients with cancer receiving immune checkpoint inhibitors: a systematic review [J].
Barron, Carly C. ;
Stefanova, Isabella ;
Cha, Yevin ;
Elsolh, Karam ;
Zereshkian, Arman ;
Gaafour, Nessma ;
McWhirter, Elaine .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
[10]   Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer [J].
Berner, Fiamma ;
Bomze, David ;
Diem, Stefan ;
Ali, Omar Hasan ;
Faessler, Mirjam ;
Ring, Sandra ;
Niederer, Rebekka ;
Ackermann, Christoph J. ;
Baumgaertner, Petra ;
Pikor, Natalia ;
Cruz, Cristina Gil ;
van de Veen, Willem ;
Akdis, Muebeccel ;
Nikolaev, Sergey ;
Laeubli, Heinz ;
Zippelius, Alfred ;
Hartmann, Fabienne ;
Cheng, Hung-Wei ;
Hoenger, Gideon ;
Recher, Mike ;
Goldman, Jonathan ;
Cozzi, Antonio ;
Fruek, Martin ;
Neefjes, Jacques ;
Driessen, Christoph ;
Ludewig, Burkhard ;
Hegazy, Ahmed N. ;
Jochum, Wolfram ;
Speiser, Daniel E. ;
Flatz, Lukas .
JAMA ONCOLOGY, 2019, 5 (07) :1043-1047